Institutional investors purchased a net $2.3 million shares of NEO during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 59.45% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONCEPT CAPITAL MARKETS LLC Bought 669.0 Thousand shares of Neogenomics Inc
RUSSELL INVESTMENT MANAGEMENT CO... Bought 540.4 Thousand shares of Neogenomics Inc
RMB CAPITAL MANAGEMENT LLC Bought 312.6 Thousand shares of Neogenomics Inc